Evidence map›Paper›PMID 35924267›Full record

ReviewBioMed research international2022

Protein PEGylation: Navigating Recombinant Protein Stability, Aggregation, and Bioactivity.

Lindiwe Khumbuzile Zuma, Nothando Lovedale Gasa, Xolani Henry Makhoba, Ofentse Jacob Pooe

Abstract readReview
In one paragraph

Review in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. The dual role of polyethylene glycol-simulated drought stress inPhysiology and molecular biology of plants : an international journal of functional plant biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Current pharmaceutical biotechnology · 2025
    Article
  11. Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lindiwe Khumbuzile ZumaDiscipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Westville, 3629 KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0003-1013-4726
Nothando Lovedale GasaDiscipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Westville, 3629 KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0001-8545-7461
Xolani Henry MakhobaDepartment of Biochemistry and Microbiology, University of Fort Hare, Alice Campus, Alice, 5700 Eastern Cape, South Africa.ORCID https://orcid.org/0000-0002-7238-4619
Ofentse Jacob PooeDiscipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Westville, 3629 KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0002-2967-7846

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes play a powerful role as catalysts with high specificity and activity under mild environmental conditions. Significant hurdles, such as reduced solubility, reduced shelf-life, aggregate formation, and toxicity, are still ongoing struggles that scientists come across when purifying recombinant proteins. Over the past three decades, PEGylation techniques have been utilized to significantly overcome low solubility; increased protein stability, shelf-life, and bioactivity; and prevented protein aggregate formation. This review seeks to highlight the impact of PEG-based formulations that are significantly utilized to obtain favourable protein physiochemical properties. The authors further discuss other techniques that can be employed such as coexpression studies and nanotechnology-based skills to obtaining favourable protein physiochemical properties.

Indexed as

Polyethylene GlycolsDrug CompoundingProtein StabilityRecombinant ProteinsSolubilityPolyethylene GlycolsRecombinant Proteins

Identifiers

PMID35924267
PMCPMC9343206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.